AkzoNobel Will Sell Zeta Fraction To Ashland

July 17, 2015
AkzoNobel annouces the sale of its biomaterials technology to Ashland Inc.

AkzoNobel announces the sale of its biomaterials technology to Ashland Inc. The transaction is expected to be complete in the third quarter of this year.

The business is in its early phase of commercialization and the divestment of the biomaterials technology follows a strategic review of the business' fit within AkzoNobel's portfolio, according to the company. The transaction enables AkzoNobel to focus on its core technology platforms - specialty surfactants and polymers.

The biomaterials activities are focused on plant-based chemistry, which is used to develop products for various applications, such as high performance beauty technologies.

For more information, visit: www.akzonobel.com

Sponsored Recommendations

Connect with an Expert!

Our measurement instrumentation experts are available for real-time conversations.

Maximize Green Hydrogen Production with Advanced Instrumentation

Discover the secrets to achieving maximum production output, ensuring safety, and optimizing profitability through advanced PEM electrolysis.

5 Ways to Improve Green Hydrogen Production Using Measurement Technologies

Watch our video to learn how measurement solutions can help solve green hydrogen production challenges today!

How to Solve Green Hydrogen Challenges with Measurement Technologies

Learn How Emerson's Measurement Technologies Tackle Renewable Hydrogen Challenges with Michael Machuca.